TABLE 1.
Patient demographics among solid organ transplant recipients with and without COVID-19
| Variable | COVID+ (n/%), N = 1925 (10.6%) | COVID− (n/%), N = 16 196 (89.4%) | P |
|---|---|---|---|
| Sex | |||
| Male | 1156 (60.1) | 9521 (58.8) | 0.286 |
| Female | 769 (39.9) | 6675 (41.2) | |
| Age | <0.001a | ||
| 18–45 y | 499 (25.9) | 3629 (22.4) | |
| 45–65 y | 951 (49.4) | 7900 (48.8) | |
| >65 y | 475 (24.7) | 4667 (28.8) | |
| Race | <0.001a | ||
| White | 776 (40.3) | 9768 (60.3) | |
| Black or African American | 620 (32.2) | 3376 (20.8) | |
| Hispanic or Latino | 324 (16.8) | 1689 (10.4) | |
| Other/unknown | 205 (10.6) | 1363 (8.4) | |
| Organ type | <0.001a | ||
| Kidney | 1399 (72.7) | 9415 (58.1) | |
| Liver | 327 (17.0) | 4041 (25.0) | |
| Lung | 139 (7.2) | 2342 (14.5) | |
| Other/unknown | 243 (12.6) | 2178 (13.4) | |
| Comorbidities | |||
| CKD | 1444 (75.0) | 9399 (58.0) | <0.001a |
| Hypertension | 1669 (86.7) | 10889 (67.2) | <0.001a |
| Diabetes | 1198 (62.2) | 7851 (48.5) | <0.001a |
| Asthma | 335 (17.4) | 2495 (15.4) | 0.024a |
| Cancer | 459 (23.8) | 3081 (19.0) | <0.001a |
| Coronary artery disease | 1311 (68.1) | 9016 (55.7) | <0.001a |
| Congestive heart failure | 590 (30.6) | 4068 (25.1) | <0.001a |
| Peripheral vascular disease | 523 (27.2) | 2992 (18.5) | <0.001a |
| Liver disease | 556 (28.9) | 4842 (29.9) | 0.372 |
| Obesity | 487 (25.3) | 4000 (24.7) | 0.001a |
| Obesity missing | 677 (35.2) | 5141 (31.7) | 0.001a |
| Immunosuppression | |||
| Prednisone | 1332 (69.2) | 10230 (63.2) | <0.001a |
| Tacrolimus | 1415 (73.5) | 10271 (63.4) | <0.001a |
| Cyclosporine | 167 (8.7) | 1439 (8.9) | 0.792 |
| MMF | 1319 (68.5) | 9535 (58.9) | <0.001a |
| ATG induction | 199 (10.3) | 1123 (6.9) | <0.001a |
| Basiliximab induction | 63 (3.3) | 976 (6.0) | <0.001a |
a Statistically significant at a P < 0.05.
ATG, antithymocyte globulin; CKD, chronic kidney disease; COVID−, negative result from COVID-19 testing; COVID+, positive result from COVID-19 testing; COVID-19, coronavirus disease 2019; MMF, mycophenolate mofetil.